{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T23:27:11Z","timestamp":1783034831475,"version":"3.54.6"},"reference-count":62,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,17]],"date-time":"2013-07-17T00:00:00Z","timestamp":1374019200000},"content-version":"vor","delay-in-days":2389,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1016\/j.seizure.2006.10.001","type":"journal-article","created":{"date-parts":[[2006,11,16]],"date-time":"2006-11-16T14:16:22Z","timestamp":1163686582000},"page":"22-34","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["Homocysteine and bone loss in epilepsy"],"prefix":"10.1016","volume":"16","author":[{"given":"John O.","family":"Elliott","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercedes P.","family":"Jacobson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zulfi","family":"Haneef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.seizure.2006.10.001_bib1","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1053\/seiz.1999.0301","article-title":"Bone density and antiepileptic drugs: a case controlled study","volume":"9","author":"Stephen","year":"1999","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2006.10.001_bib2","unstructured":"U.S. Department of Health and Human Services. Bone health and osteoporosis: A report of the surgeon general. Rockville, MD: U.S. Department of Health and Human Services, Office of the Surgeon General [online]. 2004 [cited 2005 September 8]. Available from: URL: http:\/\/www.surgeongeneral.gov\/library."},{"key":"10.1016\/j.seizure.2006.10.001_bib3","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s001980050224","article-title":"Interim report and recommendations of the World Health Organization task-force for osteoporosis","volume":"10","author":"Genant","year":"1999","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.seizure.2006.10.001_bib4","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/00013614-200501000-00003","article-title":"Estimating the opportunity costs of osteoporosis in the United States","volume":"21","author":"Vanness","year":"2005","journal-title":"Top Geriatr Rehabil"},{"key":"10.1016\/j.seizure.2006.10.001_bib5","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0025-6196(11)62214-3","article-title":"Secondary causes of osteoporosis","volume":"77","author":"Fitzpatrick","year":"2002","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.seizure.2006.10.001_bib6","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/0387-7604(94)90125-2","article-title":"Effects of anti-epileptic drug therapy on bone mineral density in ambulatory children","volume":"16","author":"Chung","year":"1994","journal-title":"Brain Dev"},{"key":"10.1016\/j.seizure.2006.10.001_bib7","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1046\/j.1528-1157.2001.416800.x","article-title":"Long-term valproate and lamotrigine treatment may be a marker for reduced growth and bone mass in children with epilepsy","volume":"42","author":"Guo","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2006.10.001_bib8","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1111\/j.0013-9580.2004.17504.x","article-title":"The epidemiology of the co-morbidity of epilepsy in the general population","volume":"45","author":"Gaitatzis","year":"2004","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2006.10.001_bib9","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.0013-9580.2005.23804.x","article-title":"Incidence of fractures among epilepsy patients: a population-based retrospective cohort study in the general practice research database","volume":"46","author":"Souverein","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2006.10.001_bib10","unstructured":"National Institutes of Health. Osteoporosis prevention, diagnosis and therapy. NIH Consensus Statement. 2000; 17:1\u201352. [cited 2005 January 14]. Available from: URL: http:\/\/odp.od.nih.gov\/consensus\/cons\/111\/111_intro.htm."},{"key":"10.1016\/j.seizure.2006.10.001_bib11","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1212\/01.WNL.0000125185.74276.D2","article-title":"Antiepileptic drug use increases rates of bone loss in older women: a prospective study","volume":"62","author":"Ensrud","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2006.10.001_bib12","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1001\/archneur.59.5.781","article-title":"Antiepileptic drug-induced bone loss in young male patients who have seizures","volume":"59","author":"Andress","year":"2002","journal-title":"Arch Neurol"},{"key":"10.1016\/j.seizure.2006.10.001_bib13","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S1525-5050(03)00036-2","article-title":"Bone mineral density in an outpatient population receiving enzyme-inducing antiepileptic drugs","volume":"4","author":"Pack","year":"2003","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.seizure.2006.10.001_bib14","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1212\/WNL.57.3.445","article-title":"Decreased bone mass and increased bone turnover with valproate therapy in adults with epilepsy","volume":"57","author":"Sato","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2006.10.001_bib15","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S0022-3476(95)70304-7","article-title":"Effect of carbamazepine and valproate on bone mineral density","volume":"127","author":"Sheth","year":"1995","journal-title":"J Pediatr"},{"key":"10.1016\/j.seizure.2006.10.001_bib16","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/ana.20378","article-title":"Bone mass and turnover in women with epilepsy on antiepileptic drug therapy","volume":"57","author":"Pack","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1016\/j.seizure.2006.10.001_bib17","doi-asserted-by":"crossref","first-page":"729","DOI":"10.3949\/ccjm.71.9.729","article-title":"Homocysteine: is it a clinically important cardiovascular risk factor?","volume":"71","author":"Lentz","year":"2004","journal-title":"Cleve Clin J Med"},{"key":"10.1016\/j.seizure.2006.10.001_bib18","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0920-1211(01)00288-1","article-title":"Antiepileptic drugs as independent predictors of plasma total homocysteine levels","volume":"47","author":"Apeland","year":"2001","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.seizure.2006.10.001_bib19","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0920-1211(02)00153-5","article-title":"The effect of B-vitamins on hyperhomocysteinemia in patients on antiepileptic drugs","volume":"51","author":"Apeland","year":"2002","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.seizure.2006.10.001_bib20","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0387-7604(02)00163-8","article-title":"Effects of valproate and carbamazepine on serum levels of homocysteine, Vitamin B12 and folic acid","volume":"25","author":"Karabiber","year":"2003","journal-title":"Brain Dev"},{"key":"10.1016\/j.seizure.2006.10.001_bib21","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1528-1157.1999.tb00716.x","article-title":"Elevated plasma concentrations of homocysteine in antiepileptic drug treatment","volume":"40","author":"Schwaninger","year":"1999","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2006.10.001_bib22","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0022-510X(96)00256-0","article-title":"Mechanisms for reduction of serum folate by antiepileptic drugs during prolonged therapy","volume":"145","author":"Kishi","year":"1997","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.seizure.2006.10.001_bib23","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0009-9120(97)00116-1","article-title":"Homocysteine levels in patients on phenytoin therapy","volume":"30","author":"James","year":"1997","journal-title":"Clin Biochem"},{"key":"10.1016\/j.seizure.2006.10.001_bib24","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1177\/106002809502907-816","article-title":"Phenytoin-folic acid interaction","volume":"29","author":"Lewis","year":"1995","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.seizure.2006.10.001_bib25","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0026-895X(25)14998-5","article-title":"Decreased hepatic 5,10-methylenetetrahydrofolate reductase activity in mice after chronic phenytoin treatment","volume":"25","author":"Billings","year":"1984","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.seizure.2006.10.001_bib26","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2165\/00003495-198530020-00003","article-title":"Drugs and folate metabolism","volume":"30","author":"Lambie","year":"1985","journal-title":"Drugs"},{"key":"10.1016\/j.seizure.2006.10.001_bib27","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/00002826-199504000-00008","article-title":"Folate deficiency, anticonvulsant drugs and psychiatric morbidity","volume":"18","author":"Froscher","year":"1995","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.seizure.2006.10.001_bib28","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S0026-0495(99)90204-4","article-title":"A common mutation in the methylenetetrahydrofolate reductase gene is a determinant of hyperhomocysteinemia in epileptic patients receiving anticonvulsants","volume":"48","author":"Yoo","year":"1999","journal-title":"Metabolism"},{"key":"10.1016\/j.seizure.2006.10.001_bib29","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1056\/NEJMoa032739","article-title":"Homocysteine as a predictive factor for hip fractures in older persons","volume":"350","author":"McClean","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.seizure.2006.10.001_bib30","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1056\/NEJMoa032546","article-title":"Homocysteine levels and the risk of osteoporotic fractures","volume":"350","author":"Van Meurs","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.seizure.2006.10.001_bib31","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.bone.2004.04.018","article-title":"Association of plasma folate, plasma homocysteine, but not methylenetetrahydrofolate reductase C667T polymorphism, with bone mineral density in postmenopausal Iranian women: a cross-sectional study","volume":"35","author":"Goldbahar","year":"2004","journal-title":"Bone"},{"key":"10.1016\/j.seizure.2006.10.001_bib32","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.amjmed.2005.01.052","article-title":"Homocysteine as a predictive factor for hip fracture in elderly women with Parkinson's disease","volume":"118","author":"Sato","year":"2005","journal-title":"Am J Med"},{"key":"10.1016\/j.seizure.2006.10.001_bib33","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.bone.2003.07.001","article-title":"Relation of homocysteine, folate, and Vitamin B12 to bone mineral density of postmenopausal women","volume":"33","author":"Cagnacci","year":"2003","journal-title":"Bone"},{"key":"10.1016\/j.seizure.2006.10.001_bib34","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.bone.2005.04.017","article-title":"Relation between homocysteine and B-Vitamin status indicators and bone mineral density in older Americans","volume":"37","author":"Morris","year":"2005","journal-title":"Bone"},{"key":"10.1016\/j.seizure.2006.10.001_bib35","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1001\/archinte.166.1.88","article-title":"Plasma total homocysteine level and bone mineral density: the Hordaland Homocysteine Study","volume":"166","author":"Gjesdal","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.seizure.2006.10.001_bib36","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s00394-004-0531-x","article-title":"Low bone mineral density and bone mineral content are associated with low cobalamin status in adolescents","volume":"44","author":"Dhonukshe-Rutten","year":"2004","journal-title":"Eur J Nutr"},{"key":"10.1016\/j.seizure.2006.10.001_bib37","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0925-4439(95)00119-0","article-title":"Evidence for McKusick's hypothesis of deficient collagen cross-linking in patients with homocystinuria","volume":"1315","author":"Lubec","year":"1996","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.seizure.2006.10.001_bib38","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/00000441-197703000-00001","article-title":"Homocystinuria: pathogenetic mechanisms","volume":"273","author":"Grieco","year":"1977","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.seizure.2006.10.001_bib39","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s002230010038","article-title":"Association of methylenetetrahydrofolate reductase (MTHFR) polymorphism with bone mineral density in postmenopausal Japanese women","volume":"66","author":"Miyao","year":"2000","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.seizure.2006.10.001_bib40","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/j.mehy.2003.10.036","article-title":"Supplemental arginine and high-dose folate may promote bone health by supporting the activity of endothelial-type nitric oxide synthase in bone","volume":"64","author":"McCarty","year":"2005","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.seizure.2006.10.001_bib41","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1001\/jama.293.9.1082","article-title":"Effect of folate and mecobalamin on hip fractures in patients with stroke","volume":"293","author":"Sato","year":"2005","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.seizure.2006.10.001_bib42","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1528-1157.1985.tb05185.x","article-title":"Selective inhibition of homocysteine-induced seizures by glutamic acid diethyl ester and other glutamate esters","volume":"26","author":"Freed","year":"1985","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2006.10.001_bib43","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/BF00433095","article-title":"Production of convulsions in mice by the combination of methionine and homocysteine","volume":"69","author":"Freed","year":"1980","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.seizure.2006.10.001_bib44","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1006\/exnr.1997.6464","article-title":"Anticonvulsant action of both NMDA and non-NMDA receptor antagonists against seizures induced by homocysteine in immature rats","volume":"145","author":"Folbergrova","year":"1997","journal-title":"Exp Neurol"},{"key":"10.1016\/j.seizure.2006.10.001_bib45","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1093\/ajcn\/82.2.442","article-title":"Biochemical indicators of B Vitamin status in the US population after folic acid fortification: results from the National Health and Nutrition Examination Survey 1999\u20132000","volume":"82","author":"Pfeiffer","year":"2005","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.seizure.2006.10.001_bib46","unstructured":"Department of Health and Human Services. National Institutes of Health. National Heart, Lung and Blood Institute, Obesity Education Initiative. [cited 2006 February 22]. Available from: URL: http:\/\/nhlbisupport.com\/bmi."},{"key":"10.1016\/j.seizure.2006.10.001_bib47","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1373\/49.5.818","article-title":"Fasting vs nonfasting plasma homocysteine concentrations for diagnosis of hyperhomocysteinemia","volume":"49","author":"Fokkema","year":"2003","journal-title":"Clin Chem"},{"key":"10.1016\/j.seizure.2006.10.001_bib48","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1093\/clinchem\/45.8.1280","article-title":"Day-to-day, postprandial, and orthostatic variation of total plasma homocysteine","volume":"45","author":"Thirup","year":"1999","journal-title":"Clin Chem"},{"key":"10.1016\/j.seizure.2006.10.001_bib49","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1046\/j.1535-7597.2003.03306.x","article-title":"The association between antiepileptic drugs and bone disease","volume":"3","author":"Pack","year":"2003","journal-title":"Epilepsy Curr"},{"key":"10.1016\/j.seizure.2006.10.001_bib50","first-page":"1","article-title":"Practical approach to bone health in epilepsy: how to prevent, evaluate and treat","volume":"11","author":"Gloth","year":"2005","journal-title":"Epilepsy Netw News"},{"key":"10.1016\/j.seizure.2006.10.001_bib51","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/sj.ki.5000417","article-title":"Traditional and emerging cardiovascular and renal risk factors: an epidemiological perspective","volume":"70","author":"Zoccali","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.seizure.2006.10.001_bib52","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S0026-0495(97)90087-1","article-title":"Plasma total homocysteine concentrations in epileptic patients taking anticonvulsants","volume":"46","author":"Ono","year":"1997","journal-title":"Metabolism"},{"key":"10.1016\/j.seizure.2006.10.001_bib53","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1161\/01.CIR.92.10.2825","article-title":"Hyperhomocysteinemia and low pyridoxal phosphate. Common and independent reversible risk factors for coronary artery disease","volume":"92","author":"Robinson","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.seizure.2006.10.001_bib54","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1093\/oxfordjournals.aje.a115052","article-title":"Alcohol consumption and hip fractures. The Framingham Study","volume":"128","author":"Felson","year":"1998","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.seizure.2006.10.001_bib55","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s00198-004-1734-y","article-title":"Alcohol intake as a risk factor for fracture","volume":"16","author":"Kanis","year":"2005","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.seizure.2006.10.001_bib56","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/BF01623463","article-title":"The influence of alcohol consumption and the risk of vertebral deformity. European Vetebral Osteoporosis Study Group","volume":"7","author":"Naves Diaz","year":"1997","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.seizure.2006.10.001_bib57","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/BF01623938","article-title":"Bone mineral acquisition during adolescence and early adulthood: a study in 574 healthy females 10\u201324 years of age","volume":"6","author":"Sabatier","year":"1996","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.seizure.2006.10.001_bib58","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/S0140-6736(96)04214-6","article-title":"Randomized controlled trial of effect of high-impact exercise on selected risk factors for osteoporotic fractures","volume":"348","author":"Heinonen","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.seizure.2006.10.001_bib59","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1745-7599.2004.tb00450.x","article-title":"Osteoporosis prevention starts in adolescence","volume":"16","author":"Schettler","year":"2004","journal-title":"J Am Acad Nurse Pract"},{"key":"10.1016\/j.seizure.2006.10.001_bib60","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1056\/NEJM199803193381209","article-title":"The need for more Vitamin D","volume":"338","author":"Utiger","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.seizure.2006.10.001_bib61","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1056\/NEJM200502033520521","article-title":"Normal serum Vitamin D levels","volume":"352","author":"Hollis","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.seizure.2006.10.001_bib62","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s002230010024","article-title":"Bone mineral densitometry substantially influences health-related behaviors of postmenopausal women","volume":"66","author":"Marci","year":"2000","journal-title":"Calcif Tissue Int"}],"container-title":["Seizure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131106001737?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131106001737?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T01:35:00Z","timestamp":1761010500000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131106001737"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":62,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["S1059131106001737"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2006.10.001","relation":{},"ISSN":["1059-1311"],"issn-type":[{"value":"1059-1311","type":"print"}],"subject":[],"published":{"date-parts":[[2007,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Homocysteine and bone loss in epilepsy","name":"articletitle","label":"Article Title"},{"value":"Seizure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2006.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}